Amrinone and theophylline differentially regulate cytokine and nitric oxide production in endotoxemic mice

Shock

Volumn 7, Issue 5, 1997, Pages 371-375

  Németh, Zoltán H ^a   Haskó, György ^a   Szabó, Csaba ^a,b   Vizi, E Sylvester ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMRINONE; CYCLIC AMP; CYCLIC GMP; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; ENDOTOXEMIA; MALE; METABOLISM; MOUSE;

AMRINONE; ANIMALS; CYCLIC AMP; CYCLIC GMP; CYTOKINES; ENDOTOXEMIA; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; THEOPHYLLINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031135077     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199705000-00010     Document Type: Article

References (38)

1. Beutler B, Milsark IW, Cerami A: Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869-871, 1985.
2. Dinarello CA: The proinflammatory cytokines interleukin-1 and tumor necrosis factor and the treatment of the septic shock syndrome. J Infect Dis 163:1177-1184, 1991.
3. Szabó C: The pathophysiological role of peroxynitrite in shock, inflammation, and ischaemia-reperfusion injury. Shock 6:79-88, 1996.
4. Szabó C, Wu CC, Gross SS, Thiemermann C, Perretti M, Vane JR: Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin m vivo. Eur J Pharmacol 250:157-160, 1993.
5. Szabó C, Wu CC, Mitchell JA, Gross SS, Thiemermann C, Vane JR: Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ Res 73:991-999, 1993.
6. Mossmann TR: Properties and functions of interleukin-10. Adv Immunol 56:1-26, 1994.
7. Barton BE, Jackson JV: Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model. Infect Immun 61:1496-1499, 1993.
8. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW: Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p 55. Blood 83:113-118, 1994.
9. Starnes HF Jr, Pearce MK, Tewari A, Yim JH, Zou JC, Abrams JS: Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-α challenge in mice. J Immunol 145:4185-4191, 1990.
10. Pastores SM, Haskó G, Vizi ES, Kvetan V: Cytokine production and its manipulation by vasoactive drugs. New Horiz 4:252-264, 1996.
11. 2. J Exp Med 180:2365-2370, 1994.
12. Haskó G, Elenkov IJ, Kvetan V, Vizi ES: Differential effect of selective block of alpha-2 adrenoceptors on plasma levels of tumor necrosis factor-alpha, interIeukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice. J Endocrinol 144:457-462, 1995.
13. Elenkov U, Haskó G, Kovács K, Vizi ES: Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice. J Neuroimmunol 61:123-131, 1995.
14. Haskó G, Szabó C, Merkel K, Bencsics A, Zingarelli B, Kvetan V, Vizi ES: Modulation of lipopolysaccharide-induced tumor necrosis factor and nitric oxide production by dopamine receptor agonist and antagonists in mice. Immunol Lett 49:143-147, 1996.
15. Haskó G, Szabó C, Németh ZH, Kvetan V, Pastores SM, Vizi ES: Adenosine receptor agonists differentially regulate IL-10, TNF-α and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol 157:4634-4640, 1996.
16. Nicholson CD, Challis RAJ, Shahid M: Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol Sci 12:19-27, 1991.
17. Murray KJ, England PJ, Hallam TJ, Maguire J, Moores K, Reeves ML, Simpson AWM, Rink TJ: The effects of siguazodan, a selective phos-phodiesterase inhibitor, on human platelet function. Br J Pharmacol 99:612-616, 1990.
18. White JR, Torphy TJ, Christensen SB, Lee JA, Mong S: Purification and characterization of the rolipram sensitive, low Km phosphodiesterase from human monocytes. FASEB J 4:A1987, 1990.
19. Verghese MW, McConnell RT, Strickland AB, Gooding RC, Stimpson SA, Yarnall DP, Taylor JD, Furdon PJ: Differential regulation of human monocyte-derived TNF-α and IL-1β by type IV cAMP-phosphodieterase (cAMP-PDE) inhibitors. J Pharmacol Exp Ther 272:1313-1320, 1995.
20. Souness JE, Griffin M, Maslen C, Ebsworth K, Scott LC, Pollock K, Palfreyman MM, Karlsson JA: Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF-α generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer. Br J Pharmacol 118:649-658, 1996.
21. Napier-Flood FE, Creese BR: Theophylline. Med J Austr 162:548-550, 1995.
22. Zingarelli B, Salzman AL, Szabó C: Protective effects of nicotinamide against nitric oxide-mediated vascular failure in endotoxic shock: Potential involvement of polyADP ribosyl synthetase. Shock 5:258-264, 1996.
23. Jilg S, Barsig J, Leist M, Küsters S, Volk HD, Wendel A: Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock. J Pharmacol Exp Ther 278:421-431, 1996.
24. Kambayashi T, Jacob CO, Zhou D, Mazurek N, Fong M, Strassmann G: Cyclic nucleotide phophodiesterese type IV participates in regulation of IL-10 and the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages. J Immunol 155:4909-4916, 1995.
25. Meisel C, Vogt K, Platzer C, Randow F, Liebenthal C, Volk HD: Differential regulation of monocytic tumor necrosis factor-α and interleukin-10 expression. Eur J Immunol 26:1580-1586, 1996.
26. Kauffman RF, Schenck KW, Utterback BG, Crowe VG, Cohen ML: In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides. J Pharmacol Exp Ther 242:864-872, 1987.
27. 2 and cyclic nucleotides. J Immunol 141:2388-2393, 1988.
28. Giroir BP, Beutler B: Effect of amrinone on tumor necrosis factor production in endotoxic shock. Ore Shock 36:200-207, 1992.
29. Endres S, Sinha B, Fülle HJ: Amrinone suppresses the synthesis of tumor necrosis factor-α in human mononuclear cells. Shock 5:377-380, 1994.
30. Sinha B, Semmler J, Eisenhut T, Eigler A, Endres S: Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids. Eur J Immunol 25:147-153, 1995.
31. Thiemermann C, Wu CC, Szabó C, Peretti M, Vane JR: Tumor necrosis factor is an endogenous mediator of the induction of nitric oxide synthase in endotoxin shock in the rat. Br J Pharmacol 110:177-182, 1993.
32. Szabó C, Haskó G, Zingarelli B, Németh ZH, Salzman AL, Kvetan V, Pastores SM, Vizi ES: Isoproterenol regulates TNF, IL-10 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxemia. Immunology 90:95-100, 1997.
33. Haskó G, Nerneth ZH, Vizi ES, Szabó C: Anti-inflammatory profile of dantrolene: Inhibition of endotoxin-induced tumor necrosis factor and enhancement of interleukin-10 production, but no effect on nitric oxide and interIeukin-6 production. Shock 5:S45, 1996.
34. Jurasinski CV, Kilpatrick L, Vary TC: Amrinone prevents muscle protein wasting during chronic sepsis. Am J Physiol 268:E491-E500, 1995.
35. Mancini D, LeJemtel T, Sonnenblick E: Intravenous use of amrinone for the treatment of the failing heart. Am J Cardiol 56:8B-15B, 1985.
36. Hotchkiss RS, Osbome DF, Lappas GD, Karl IE: Calcium antagonists decrease plasma and tissue concentrations of tumor necrosis factor-α, interleukin-1β, and interleukin-1α in a mouse model of endotoxin. Shock 3:337-342, 1995.
37. Standiford TJ, Stricter RM, Lukacs NW, Kunkel SL: Neutralization of IL-10 increases lethality in endotoxemia: Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol 155:2222-2229, 1995.
38. Ertel W, Keel M, Steckholzer U, Ungethüm U, Trentz O: Interleukin-10 attenuates the release of proinflammatory cytokines but depresses splenocyte functions in murine endotoxemia. Arch Surg 131:51-56, 1996.